Expert Council: promising areas of systemic enzyme therapy in gynecology

Y. Dobrokhotova, A. Khryanin, E. Shikh, L. Karakhalis, I. M. Ordiyants, E. A. Kogan, A. V. Yakimova, I. Korotkikh, N.I. Kokhno
{"title":"Expert Council: promising areas of systemic enzyme therapy in gynecology","authors":"Y. Dobrokhotova, A. Khryanin, E. Shikh, L. Karakhalis, I. M. Ordiyants, E. A. Kogan, A. V. Yakimova, I. Korotkikh, N.I. Kokhno","doi":"10.32364/2618-8430-2023-6-2-149-156","DOIUrl":null,"url":null,"abstract":"The interdisciplinary scientific and practical conference «Expert Council: promising areas of systemic enzyme therapy (SET) in gynecology» under the auspices of the National Association of Obstetricians-Gynecologists and Reproductologists \"Women's Health\" was held in Moscow on December 02, 2022. The conference brought together specialists from multiple Russian regions. The development of effective treatment algorithms for infection-caused inflammatory diseases in the practices of obstetricians and gynecologists remains relevant in view of the continuous growth of antimicrobial resistance underpinned both by the irrational use of antibiotics and the biofilm-forming ability of infectious agents. The speakers shared their experience of using systemic enzyme therapy (SET) in the combination treatment of inflammatory diseases in obstetric and gynecological practice, as well as in the prevention of fibrous and adhesive complications of pelvic inflammatory diseases (PID) and gynecologic surgeries. It was pointed out that systemic enzyme therapy should be recognized as a justified component of the combination PID treatment which helps to reduce the duration and severity of symptoms due to its proven immunomodulatory, fibrinolytic and antiplatelet effects. The use of SET drugs reduces the duration of all stages of reparative regeneration along with tamping down the inflammatory response. The Expert Council Resolution provides recommendations on using SET in gynecology. KEYWORDS: proteolytic enzymes, pelvic inflammatory diseases, endometritis, adhesions, antibiotic resistance, systemic enzyme therapy. FOR CITATION: Dobrokhotova Yu.E., Khryanin A.A., Shikh E.V. et al. Expert Council: promising areas of systemic enzyme therapy in gynecology. Russian Journal of Woman and Child Health. 2023;6(2):149–156 (in Russ.). DOI: 10.32364/2618-8430-2023-6-2-149-156.","PeriodicalId":34075,"journal":{"name":"RMZh Mat'' i ditia","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"RMZh Mat'' i ditia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32364/2618-8430-2023-6-2-149-156","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The interdisciplinary scientific and practical conference «Expert Council: promising areas of systemic enzyme therapy (SET) in gynecology» under the auspices of the National Association of Obstetricians-Gynecologists and Reproductologists "Women's Health" was held in Moscow on December 02, 2022. The conference brought together specialists from multiple Russian regions. The development of effective treatment algorithms for infection-caused inflammatory diseases in the practices of obstetricians and gynecologists remains relevant in view of the continuous growth of antimicrobial resistance underpinned both by the irrational use of antibiotics and the biofilm-forming ability of infectious agents. The speakers shared their experience of using systemic enzyme therapy (SET) in the combination treatment of inflammatory diseases in obstetric and gynecological practice, as well as in the prevention of fibrous and adhesive complications of pelvic inflammatory diseases (PID) and gynecologic surgeries. It was pointed out that systemic enzyme therapy should be recognized as a justified component of the combination PID treatment which helps to reduce the duration and severity of symptoms due to its proven immunomodulatory, fibrinolytic and antiplatelet effects. The use of SET drugs reduces the duration of all stages of reparative regeneration along with tamping down the inflammatory response. The Expert Council Resolution provides recommendations on using SET in gynecology. KEYWORDS: proteolytic enzymes, pelvic inflammatory diseases, endometritis, adhesions, antibiotic resistance, systemic enzyme therapy. FOR CITATION: Dobrokhotova Yu.E., Khryanin A.A., Shikh E.V. et al. Expert Council: promising areas of systemic enzyme therapy in gynecology. Russian Journal of Woman and Child Health. 2023;6(2):149–156 (in Russ.). DOI: 10.32364/2618-8430-2023-6-2-149-156.
专家委员会:妇科系统酶治疗的有前景的领域
2022年12月2日,由全国妇产科和生殖医师协会主办的“妇女健康”跨学科科学和实践会议“专家委员会:妇科系统酶治疗(SET)的有前途领域”在莫斯科举行。会议汇集了来自俄罗斯多个地区的专家。鉴于抗生素的不合理使用和感染因子的生物膜形成能力所导致的抗菌素耐药性的持续增长,在妇产科医生的实践中,开发有效的治疗算法对感染引起的炎症性疾病仍然具有重要意义。演讲者分享了他们在产科和妇科实践中使用全身酶疗法(SET)联合治疗炎症性疾病,以及预防盆腔炎(PID)和妇科手术的纤维和粘连并发症的经验。有人指出,全身性酶治疗应被认为是联合PID治疗的合理组成部分,由于其已证实的免疫调节、纤溶和抗血小板作用,有助于缩短症状的持续时间和严重程度。SET药物的使用减少了修复性再生的所有阶段的持续时间,同时抑制了炎症反应。专家委员会决议提供了在妇科使用SET的建议。关键词:蛋白水解酶,盆腔炎,子宫内膜炎,粘连,抗生素耐药,全身酶治疗。引文:Dobrokhotova Yu.E。, Khryanin a.a., Shikh E.V.等。专家委员会:妇科系统酶治疗的有前景的领域。俄罗斯妇女与儿童健康杂志。2023;6(2):149-156。DOI: 10.32364 / 2618-8430-2023-6-2-149-156。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.60
自引率
0.00%
发文量
14
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信